Pages that link to "Q33332323"
Jump to navigation
Jump to search
The following pages link to Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity (Q33332323):
Displaying 12 items.
- Equilibrative nucleoside transporters-A review (Q30244329) (← links)
- Role of transmembrane domain 4 in ligand permeation by Crithidia fasciculata equilibrative nucleoside transporter 2 (CfNT2). (Q33673397) (← links)
- Tyrosine 112 Is Essential for Organic Cation Transport by the Plasma Membrane Monoamine Transporter (Q34367791) (← links)
- Purine import into malaria parasites as a target for antimalarial drug development (Q35513431) (← links)
- Residue Ile89 in human plasma membrane monoamine transporter influences its organic cation transport activity and sensitivity to inhibition by dilazep (Q36024314) (← links)
- Cysteine cross-linking defines the extracellular gate for the Leishmania donovani nucleoside transporter 1.1 (LdNT1.1). (Q36492732) (← links)
- Functional characterization of human equilibrative nucleoside transporter 1. (Q37712414) (← links)
- Nucleoside/nucleobase transporters: drug targets of the future? (Q37855808) (← links)
- Identification of a novel point mutation in ENT1 that confers resistance to Ara-C in human T cell leukemia CCRF-CEM cells (Q39950095) (← links)
- Selective Inhibition of Human Equilibrative and Concentrative Nucleoside Transporters by BCR-ABL Kinase Inhibitors: IDENTIFICATION OF KEY hENT1 AMINO ACID RESIDUES FOR INTERACTION WITH BCR-ABL KINASE INHIBITORS. (Q41002630) (← links)
- Structures of human ENT1 in complex with adenosine reuptake inhibitors (Q93001118) (← links)
- IMPROvER: the Integral Membrane Protein Stability Selector (Q99557365) (← links)